Showcasing Clinical Success of a Novel STMN2-Targeting ASO to Restore Functional Expression & Promote Motor Neuronal Repair

Time: 1:40 pm
day: Day Two Track B PM


  • Outlining latest advancements in the QRL-201 program
  • Achieving successful restoration of STATHMIN-2 expression in ALS patients
  • Highlighting upcoming steps in the advancement of QRL-201 towards later phase studies